| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/18/2003 | US20030175969 Prevention infant blood disorders |
| 09/18/2003 | US20030175937 Cathepsin O2 protease |
| 09/18/2003 | US20030175933 Mutants; detergents; active materials; oxidation resistance |
| 09/18/2003 | US20030175931 DNA molecules coding for debranching enzymes derived from plants |
| 09/18/2003 | US20030175928 Mitogen-activated protein kinase MEK6 and methods of use therefor |
| 09/18/2003 | US20030175915 Process for the preparation of beta-keto aliphatic acid ester |
| 09/18/2003 | US20030175900 Compositions and methods for the treatment of tumor |
| 09/18/2003 | US20030175899 Form fungi culture; for pretanning leather |
| 09/18/2003 | US20030175897 Human interferon, Zinf2 |
| 09/18/2003 | US20030175895 Chemokine |
| 09/18/2003 | US20030175888 Discrete acyltransferases associated with type I polyketide synthases and methods of use |
| 09/18/2003 | US20030175884 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 09/18/2003 | US20030175882 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175881 Nucleic acids encoding (poly) peptides having chips activity |
| 09/18/2003 | US20030175880 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175879 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175878 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175877 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175876 a neurotrophin with biological activity on the central/peripheral nervous system cells; used for treating GDNF-responsive conditions such as alzhiemer's, parkinsons; device for nerve damage treatment |
| 09/18/2003 | US20030175875 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175874 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175873 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175872 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175871 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175870 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175869 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175868 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175867 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175866 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175865 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175859 Fluorescent proteins |
| 09/18/2003 | US20030175855 Human sdf-5 protein and compositions |
| 09/18/2003 | US20030175840 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease |
| 09/18/2003 | US20030175823 Method of screening remedy for heart failures |
| 09/18/2003 | US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 09/18/2003 | US20030175739 Nucleic acids, proteins, and antibodies |
| 09/18/2003 | US20030175715 Compositions and methods relating to breast specific genes and proteins |
| 09/18/2003 | US20030175311 A protein encoded by DNA sequence, for protecting poultry; veterinary medicine |
| 09/18/2003 | US20030175304 Recombinant dimeric envelope vaccine against flaviviral infection |
| 09/18/2003 | US20030175296 Chimaeric hepadnavirus core antigen proteins |
| 09/18/2003 | US20030175289 TIE ligands |
| 09/18/2003 | US20030175288 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology |
| 09/18/2003 | US20030175280 Antagonists to chaperonin 10 |
| 09/18/2003 | US20030175276 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents |
| 09/18/2003 | US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 09/18/2003 | US20030175273 Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens |
| 09/18/2003 | US20030175246 Toxin-phage bacteriocide antibiotic and uses thereof |
| 09/18/2003 | US20030175186 Process and apparatus for performing a gas-sparged reaction |
| 09/18/2003 | CA2478593A1 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | CA2478572A1 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
| 09/18/2003 | CA2478369A1 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 09/18/2003 | CA2478346A1 Specific ab1'-antibodies against tumour-associated antigen ca 125 |
| 09/18/2003 | CA2478177A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/18/2003 | CA2478102A1 Antigens and their use as diagnostics and vaccines against species of plasmodium |
| 09/18/2003 | CA2478032A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/18/2003 | CA2478029A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins |
| 09/18/2003 | CA2477273A1 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/17/2003 | EP1344827A2 Antifreeze proteins from basidiomycetes |
| 09/17/2003 | EP1344826A1 Materials comprising and methods of preparation and use for ribosome - inactivating proteins |
| 09/17/2003 | EP1344530A1 Interleukin-18 inducing agent |
| 09/17/2003 | EP1343909A2 Methods for large scale protein production in prokaryotes |
| 09/17/2003 | EP1343895A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 09/17/2003 | EP1343891A2 Colon cancer marker |
| 09/17/2003 | EP1343890A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/17/2003 | EP1343889A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 09/17/2003 | EP1343888A2 Regulation of human chemokine-like receptor |
| 09/17/2003 | EP1343887A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 09/17/2003 | EP1343880A2 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 09/17/2003 | EP1343822A2 Means for the diagnosis and therapy of ctcl |
| 09/17/2003 | EP1343818A1 Modified tachykinin receptors |
| 09/17/2003 | EP1343813A1 Novel compounds |
| 09/17/2003 | EP1343812A1 Protein cluster ii |
| 09/17/2003 | EP1343811A1 Methods for preparing purified lipopeptides |
| 09/17/2003 | EP1343784A2 Urea substituted imidazoquinoline ethers |
| 09/17/2003 | EP1159295B1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 09/17/2003 | EP1124941B1 Process for recovering heterologous polypeptides from bacterial cells |
| 09/17/2003 | EP0981627B1 Purified telomerase |
| 09/17/2003 | EP0972782B1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 09/17/2003 | EP0842428B1 Process for producing gm2 specific antibodies |
| 09/17/2003 | EP0840784B1 Method of producing and purifying enzymes |
| 09/17/2003 | EP0831937B1 Immunological combination compositions and methods |
| 09/17/2003 | EP0697888B1 Conserved motif of hepatitis c virus e2/ns1 region |
| 09/17/2003 | EP0669988B1 Angiogenesis inhibitory antibodies |
| 09/17/2003 | EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 09/17/2003 | CN1443242A Modified construct downstream of initiation codon for recombinant protein over expression |
| 09/17/2003 | CN1443241A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 09/17/2003 | CN1443240A Interferon-like protein zcyto 21 |
| 09/17/2003 | CN1443199A Antibodies to human MCP-1 |
| 09/17/2003 | CN1443196A Protein complex serving as vehicle for orally administerable medicaments |
| 09/17/2003 | CN1443194A Methods for refolding proteins containing free cysteine residues |
| 09/17/2003 | CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/17/2003 | CN1443077A CD40-binding APC-activating molecules |
| 09/17/2003 | CN1443074A Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury |
| 09/17/2003 | CN1442481A PBAD expression system of human source fragment antibody |
| 09/17/2003 | CN1442430A AsLc-IFN fusion protein and its preparation |
| 09/17/2003 | CN1442427A Trimutant of recombinant human interleukin-2 and its preparation method |
| 09/17/2003 | CN1121497C D-pantolactone hydrolase and gene encoding the same |
| 09/17/2003 | CN1121411C Efficient gene engineering process for preparing polypeptide medicines |
| 09/16/2003 | US6620923 Use for treatment of uterine cancer |
| 09/16/2003 | US6620917 Mixing polypeptide with a organic acid, incubating and clarifying; hydrolysis; chromatography; use for light weight, high performance fiber, composite and medical applications; formic, acetic, propionic, butyric, valeric acids |